relevant off-label use (prescriber must submit supporting evidence). VII. References. 1. Vectibix Prescribing Information. Thousand Oaks
These highlights do not include all the information needed to use VECTIBIX safely and effectively. See full prescribing information for VECTIBIX. VECTIBIX (panitumumab) Injection for intravenous use Initial US Approval: 2024 . WARNING: DERMATOLOGIC TOXICITY. See full prescribing information for complete boxed warning.
Vectibix Prescribing Information. Thousand Oaks, CA: Amgen, Inc.; August 2024. Available at Accessed Aug. 2. National
More information is in Section 4. How will I be given Vectibix? in This medicine is only available with a doctor's prescription. What VECTIBIX contains.
Prescribing Information brochure (package insert - Section 12, Table combination with Braftovi and either Erbitux or Vectibix. 176
Please click here to see Vectibix package insert for full Prescribing. Information, including Boxed WARNING. Page 4. IMPORTANT SAFETY INFORMATION (cont'd). In
These highlights do not include all the information needed to use Vectibix safely and effectively. See full prescribing information for Vectibix. Vectibix (panitumumab) Injection for Intravenous Use . Initial US Approval: 2024 . WARNING: DERMATOLOGIC TOXICITY and INFUSION . REACTIONS . See full prescribing information for complete boxed
To communicate the risk of SJS and TEN, Amgen is proposing to update the Vectibix prescribing information to include SJS and TEN within the Special Warnings
These highlights do not include all the information needed to use VECTIBIX safely and effectively. See full prescribing information for VECTIBIX. VECTIBIX (panitumumab) Injection for intravenous use . Initial US Approval: 2024 . WARNING: DERMATOLOGIC TOXICITY See full prescribing information for complete boxed warning.
Comments